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Abstract The interferon regulatory factor (IRF) family of
transcription factors regulate the interferon (IFN) system,
among which IRF-3 is involved in the virus-induced IFN-L gene
expression. Here we show that another member IRF-7 is critical
for the IFN-K gene induction. Unlike the IRF-3 gene, the IRF-7
gene is induced by IFNs through activation of the ISGF3
transcription factor, and IRF-7 undergoes virus-induced nuclear
translocation. In cells lacking p48, an essential component of
IFN stimulated gene factor 3 (ISGF3), ectopic expression of
IRF-7 but not IRF-3 can rescue the deficiency to induce IFN-K
genes. These results indicate that IRF-7 is a key factor in the
positive feedback regulation of IFN-K/L production.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Induction of type I interferon (IFN-Ks and -L) gene tran-
scription in virally infected cells is essential for the host de-
fense [1,2]. The interferon regulatory factor (IRF) family of
transcription factors was originally identi¢ed as regulators of
the IFN system [3^5]. It has been shown that IRF-1 and p48,
essential components of ISGF3 (IFN-stimulated gene factor
3), are critical for the IFN-mediated antiviral response [6,7].
Recent studies have suggested that another member of the
IRF family, IRF-3, plays a critical role in the virus-induced
IFN-L gene activation [8^13]. In fact, in normally growing
cells IRF-3 resides in the cytoplasm and, upon virus infection
of the cells, it is phosphorylated and translocates into the
nucleus. The ‘activated’ IRF-3 associates with the co-activa-
tors CBP/p300 and enhances transcription of the IFN-L pro-
moter. These results strongly suggest that IRF-3 is the bona
¢de transcriptional activator acting on the IRF binding ele-
ments within the virus-inducible IFN-L promoter (IRF-Es
[14]; also referred to as PRDI and III [15,16]). Although the
IFN-K promoters also contain sequences characteristic for
IRF-E, it appears that the induction of IFN-K genes is con-
trolled by a mechanism(s) distinct from that for the IFN-L
gene. In this regard, we originally proposed a two-step induc-
tion model for the IFN genes, in which a positive feedback
regulation mechanism of IFN production is operational to
ensure an e⁄cient production of IFN-K/L [17]. This model
can be elaborated further by incorporating recent ¢ndings
on IRF-3 as follows: IFN-L gene is primarily induced through
virus-induced activation of IRF-3, which is followed by the
inductions of IFN-K genes which are dependent on the IFN-
activated transcription factor ISGF3. Consistent with this
model are the observations that the induction of IFN-K genes,
but not IFN-L gene, by Newcastle disease virus (NDV) is
compromised in mouse embryonic ¢broblasts lacking either
functional IFN-K/L receptor or p48, the DNA binding subunit
of ISGF3, indicating the critical role of IFN-activated ISGF3
in the positive feedback regulation of IFN production [17]. In
this context, ISGF3 binding to the IFN gene promoters has
been demonstrated [17^19]. However, the question remained
as to whether or not it is ISGF3 per se or a factor(s) induced
by ISGF3 which directly mediates the IFN-K gene induction.
In fact, the kinetics of the ISGF3 activation is not in strict
correlation with the kinetics of the IFN-K gene induction in
virally infected cells [17,19], raising the possibility that the
e¡ect of ISGF3 may be indirect, that is, ISGF3 may induce
as yet another transcription factor which, when activated by
viruses, functions directly on the IFN-K promoters.
These observations led us to investigate an ISGF3-depend-
ent, IFN-inducible factor involved in the IFN-K gene tran-
scription. It has been shown that the IRF-E sequence is in-
deed essential for the activation of IFN-K promoter [20,21]. In
view of the wide-range involvement of the IRF members in
the IFN system regulation, we investigated other IRF-family
members which would ¢t into the above criteria. In particular,
we focused our attention on IRF-7, since it shows high ho-
mology to IRF-3 at the amino acid level [10] and the IRF-7
gene is induced by IFN-K in lymphoid cells [22]. In the present
study, we show that the IRF-7 gene is induced by IFN-K/L in
¢broblast cells in an ISGF3-dependent manner. The induced
IRF-7 resides in the cytoplasm, but undergoes nuclear trans-
location following NDV infection of the cells. The ectopic
expression of IRF-7, but not IRF-3, in ¢broblast cells lacking
p48 resulted in the induction of a similar set of IFN-K genes as
that induced in the wild-type ¢broblasts, following NDV in-
fection. Our results will be discussed in the context of the
positive feedback regulation of IFN-L and IFN-K genes by
two distinct IRF-family members, which may be important
in understanding the e⁄cient operation of the host defense
mechanism against viruses.
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2. Materials and methods
2.1. Construction of expression vectors
HA/IRF-7/pBabe, the retrovirus expression vector for HA-tagged
IRF-7 was constructed as follows. To obtain the mouse IRF-7 cDNA,
total RNA was prepared from mouse embryonic ¢broblasts after
IFN-L stimulation. The RNA was subjected to RT-PCR using sense
(5P-CCTGTGTAGACGGAGCAATG) and antisense (5P-TCAAG-
GCCACTGACCCAGGT) primers, and the resulting 1.4-kb cDNA
fragment was cloned into the SalI site of pEF/HA [8] and generated
pEF/HA-IRF-7. The cloned cDNA was sequenced to con¢rm its
identity to the published sequence (GenBank accession no. U73037).
The pEF/HA-IRF-7 was digested with XbaI and treated with T4
DNA polymerase, and the product was digested by EcoRI to obtain
the HA-tagged IRF-7 cDNA. The HA-tagged cDNA was then cloned
into the retrovirus vector, pBabe-puro [23].
To make the vector expressing the deletion mutant HA-IRF-7d, 1.3
kb of the EcoRI-BstXI fragment and 77 bp of the BstXI-NcoI frag-
ment were ¢rst isolated from IRF-7 cDNA and then ligated with the
backbone DNA of HA-IRF-7/pBabe pre-digested by EcoRI and PshI
(HA-IRF-7d/pBabe).
2.2. Cell culture and retrovirus infection
The p483=3 and IFNAR13=3 mice used in the study have been
described [7,24]. Wild-type and p483=3 EFs were prepared from 13-
day mouse embryos and maintained as monolayer cultures in Dulbec-
co’s modi¢ed Eagle’s medium supplemented with 10% FCS and 0.06%
L-glutamine [7]. NIH/3T3 cells were also cultured in this medium.
Retrovirus packaging was performed by cotransfection of pPAMpsi2
(kindly provided by Dr. Charles L. Sawyers, University of California,
Los Angeles, CA, USA) and HA-IRF-7/pBabe, HA-IRF-7d/pBabe,
HA-IRF-3/pBabe [8] or control pBabe-puro into 293T cells, and in-
fection of the viruses to the cells was done as described previously [8].
2.3. RNA blotting analysis
The RNA blotting analysis and preparation of the probe DNAs for
IFN-K and IFN-L have been described [17]. The 750 bp of the HindIII
fragment from pIRF-3 was used as the IRF-3 probe [8]. As for the
IRF-7 mRNA detection, the 1.4-kb EcoRI fragment from pIRF-7
containing the IRF-7 cDNA was used as a probe. Five micrograms
of total RNA was loaded on each lane.
2.4. Immuno£uorescent staining and immunoblotting analysis
The NIH-3T3-derived cells, 3T3/IRF-7 and 3T3/IRF-7d, were ¢rst
cultured for 8 h on chamber plate. After NDV infection (12 h), the
cells were ¢xed and the HA-tagged IRF-7 was visualized as described
[8]. Immunoblotting using anti-HA antibody was carried out as de-
scribed [8].
2.5. Luciferase assay
NIH/3T3 cells (8U104 cells) were cultured on a 12-well plate. 0.4 Wg
of reporter plasmid and 1.6 Wg of expression vector were cotransfected
by DEAE-dextran method. After 32 h, the cells were infected with
NDV for 12 h and the cellular extracts were prepared for the lucifer-
ase assay, as described previously [8].
3. Results
3.1. The p48-dependent induction of IRF-7 gene by IFN
We ¢rst examined the virus-induced expression of IRF-3
and IRF-7 genes in mouse embryonic ¢broblasts (EFs). As
shown in Fig. 1A, RNA blotting analysis revealed that the
IRF-7 mRNA expression is strongly induced in NDV-infected
EFs, whereas IRF-3 mRNA, which is expressed before NDV
infection, remained unchanged during the course of infection.
In fact, the IRF-7 mRNA becomes detectable at the time of
IFN-K and -L mRNA induction, and its level increased there-
after. Interestingly, the IRF-7 mRNA induction by NDV is
not observed in EFs lacking either the type I IFN receptor 1
(IFNAR1) or p48. In these cells, the induction of IFN-K gene,
but not IFN-L gene, is also compromised. These observations
indicate that the IRF-7 gene induction by NDV is not direct,
rather the gene is induced by ISGF3 following the IFN re-
ceptor stimulation by IFN-L. In fact, we found that the IRF-7
mRNA is strongly induced also by IFN-L in the wild-type
EFs, reaching a peak earlier than the NDV-infected cells.
Furthermore, this induction was again abolished in EFs lack-
ing p48 (Fig. 1B). In contrast, the IRF-3 mRNA expression is
not a¡ected by the IFN stimulation. Taken together, we con-
clude that the IRF-7 gene induction by IFN-L (and by IFN-K ;
data not shown) is mediated by ISGF3. Although the ISGF3
binding site ISRE (IFN Stimulated Response Element) [25]
was not found in the putative IRF-7 promoter region (span-
ning up to 500 nucleotides from the putative transcription
initiation site; M.S., unpublished data), two such elements,
GGTTTCATTTTCC and CAGTTTCGTTTTAC, were de-
tected within the ¢rst intron (M.S., unpublished data). It re-
mains to be clari¢ed whether or not these two elements are
involved in the ISGF3-mediated gene induction.
3.2. Activation of IFN-K genes by ectopic expression of IRF-7
in cells lacking p48
The above results suggest that the IFN-induced IRF-7 may
play a critical role in the IFN-K gene induction by NDV. To
test this possibility, we next constructed a retrovirus express-
ing an HA-tagged mouse IRF-7 (HA-IRF-7) and infected it
into EFs lacking p48. Similarly, the retrovirus expressing an
HA-tagged mouse IRF-3 (HA-IRF-3) was infected to the
cells. The NDV-induced expression of IFN-K and IFN-L
mRNAs was examined in these cells by RNA blotting (Fig.
2). The IFN-K mRNA expression was undetectable before
NDV infection, but it was strongly induced 12 h after infec-
tion in the p48 null EFs expressing HA-IRF-7. In fact, the
kinetics and levels of the mRNA induction were almost the
same as in the wild-type EFs (Fig. 2). Moreover, when we
compared the subtypes of the induced IFN-K mRNAs be-
tween the IRF-7 expressing EFs and the wild-type EFs, no
notable di¡erences were observed; the most abundant mRNA
was that of IFN-K4 mRNA, followed by IFN-K1, 2, 5, in
both cells (data not shown). In contrast, the expression of
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Fig. 1. Induction of IRF-7 and IRF-3 mRNAs in mouse EFs. A:
NDV induction of IRF-7 mRNA in EFs. Wild-type, p483=3 and
IFNAR13=3 EFs were infected with NDV, and total RNA was pre-
pared at each time point indicated and subjected to RNA blotting
analysis. B: Induction of IRF-7 mRNA by IFN-L. Wild-type and
p483=3 EFS were treated with mouse IFN-L at the concentration of
250 U/ml. At each time point indicated, total RNA was extracted
from the cells for RNA blotting analysis. Membranes were stained
with methylene blue to visualize 28S ribosomal RNA.
M. Sato et al./FEBS Letters 441 (1998) 106^110 107
HA-IRF-3 had no e¡ect on the IFN-K mRNA induction,
although the IFN-L mRNA induction level was augmented
about 3-fold compared to the wild-type EFs, an observation
consistent with the previous ¢ndings in NIH/3T3 cells (Fig. 2
and [8]). Interestingly, the retrovirus-mediated IRF-7 expres-
sion resulted also in the upregulation of the IFN-L mRNA
induction (Fig. 2). These results thus suggest that IRF-7 can
act on both IFN-K and -L genes, whereas IRF-3 acts only on
the IFN-L gene. Similar observations were also made in NIH/
3T3 ¢broblasts (data not shown).
3.3. Nuclear translocation of IRF-7 in NDV-infected cells
It is interesting to note that the forced expression of IRF-7
per se does not result in the induction of IFN-K genes, unless
the IRF-7-expressing cells are infected by NDV (Fig. 2), sug-
gesting an activation mechanism of IRF-7 in virally infected
cells. To gain further insights into this mechanism, the retro-
virus expressing HA-tagged IRF-7 was infected into NIH/3T3
cells (referred to as 3T3/IRF-7 cells thereafter) and its fate
before and after NDV infection was examined by immuno-
£uorescence staining. As shown in Fig. 3A, the HA-tagged
IRF-7 protein is predominantly found in the cytoplasm in
normally growing state. Upon NDV infection, the IRF-7 pro-
tein is accumulated in the nucleus, an observation similar to
IRF-3 [8^13]. We also expressed a deletion mutant of IRF-7
which lacks the carboxyl terminal region, 411^453 amino
acids, that contains several serine residues. This region is ho-
mologous to IRF-3, and the phosphorylation of these serines
in IRF-3 critical for the virus-induced activation/nuclear
translocation (Fig. 3A; see [9,11]). As shown in Fig. 3A, the
mutant IRF-7 is incapable of translocation upon NDV infec-
tion of the cells. This result indicates an essential role of this
region in nuclear translocation, and suggests a mechanism
similar to that for IRF-3, in which virus-induced serine phos-
phorylation of this region is critical for its activation.
To examine further the status of the ‘activated’ IRF-7, we
prepared nuclear extracts from 3T3/IRF-7 cells before and
after NDV infection, and subjected to immunoblotting anal-
ysis using anti-HA antibody. A new band which migrates
slower than that found already in uninfected cells was prom-
inent 12 h after virus infection (data not shown), the time at
which IFN-K mRNA accumulation peaks. As shown in Fig.
3B, the induction-speci¢c band disappeared by treating the
nuclear extract with calf intestinal alkaline phosphatase
(CIAP), suggesting that IRF-7 is indeed phosphorylated after
virus infection.
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Fig. 3. Status of the ectopically expressed IRF-7 before and after
NDV infection. A: Cellular localization of IRF-7. HA-tagged IRF-7
was visualized with an anti-HA monoclonal antibody and FITC
conjugated anti-mouse IgG antibody. HA-IRF-7d is the mutant of
HA-tagged IRF-7 with a deletion at the carboxyl-terminal region
containing the potential phosphorylation sites. Six serine residues
within IRF-3 which are critical for nuclear translocation [9,11], are
asterisked. DBD represents the DNA binding domain. B: Evidence
for the virus-induced phosphorylation of IRF-7. Nuclear extracts
were prepared from NDV infected or uninfected 3T3/HA-IRF-7.
The extract from NDV infected cells was treated with 18 units of
CIAP. The extracts were resolved by SDS-PAGE and HA-IRF-7
was detected by immunoblotting using anti-HA antibody. C: En-
hancement of the virus-induced IFN-K4 promoter activation by
IRF-7. Cell lysates for the luciferase assay were prepared 12 h after
NDV infection. The histogram shows the mean value of three sam-
ples and error bars show standard deviation. The experiment was
repeated and essentially the same conclusion was reached.
Fig. 2. Induction of IFN-K and -L genes by IRF-7. HA-tagged IRF-
7 or IRF-3 cDNA was introduced into p483=3 EFs by retrovirus-
mediated gene transfer (p483=3/IRF-7 and p483=3/IRF-3, respec-
tively). After puromycin selection, the cells were infected with NDV
for the time indicated and total RNA was extracted at the indicated
time for RNA blotting analysis. Membranes were stained with
methylene blue and stained 28S ribosomal RNA was indicated.
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3.4. Activation of the IFN-K promoter by IRF-7
In an electrophoretic mobility shift assay (EMSA) using the
IFN-K1 or IFN-K4-derived IRF-E, and the nuclear extracts
from 3T3/IRF-7 cells, a low mobility band was detected in
NDV-infected, but not in uninfected cells, and this band re-
acted with anti-HA antibody (data not shown). This
prompted us to study the activation of the IFN-K promoter
by IRF-7. We employed a transient assay using a reporter
gene consisting of the IFN-K4-derived IRF-E (spanning
3110 to 376 [21]) and luciferase gene (p-55K4luc [17]). As
shown in Fig. 3C, luciferase activity was signi¢cantly aug-
mented when p-55K4luc was cotransfected with an IRF-7 ex-
pression vector after NDV infection. On the other hand, this
e¡ect was not seen in the construct p-55K4mluc, in which the
IRF-E element is mutated (GAAAGTGAAAAGA to GAT-
CATGAAAAGA). Thus, IRF-7 can directly act on the IFN-
K4 promoter, provided that it is activated, probably by phos-
phorylation, following NDV infection.
4. Discussion
Both IFN-K and IFN-L genes are induced by viral infection
of the cells, and induction of these genes constitutes an essen-
tial part in the innate immune response, i.e. the immediate
host defense against viruses [1,2]. The mechanisms of regula-
tion of these genes, which operate primarily at the transcrip-
tional level, have been extensively studied. In particular, the
IRF family of transcription factors has been known to regu-
late the IFN system in both IFN production and action
[6,7,17,26,27]. Both IFN-K and -L genes contain within their
respective promoters the binding element, IRF-E (also re-
ferred to as PRD-I and III for the IFN-L gene [15,16]). Re-
cently, we and others have reported on the potential role of
IRF-3, a factor normally found in the cytoplasm in uninfected
cells, which gets activated upon viral infection to undergo
nuclear translocation and acts on the IFN-L promoter in as-
sociation with the co-activator CBP/p300 [8,13]. However, the
question has remained unanswered on the role of IRF-3 in the
IFN-K gene induction.
We have shown previously that in EFs lacking the IRF
member p48, in which the IFN-induced activator of transcrip-
tion ISGF3 cannot be formed, the IFN-K gene induction by
NDV is severely compromised [17]. We then proposed two
models of the ISGF3-mediated IFN-K gene induction; one
model argued that ISGF3 acts directly on the IFN-K pro-
moter, while the other predicted a factor, hereupon termed
X [17], which is induced by ISGF3 and acts on the promoter.
Our present study strongly supports the second model, in
which the ISGF3-induced factor X is IRF-7 (Fig. 4). In
fact, IRF-7 is induced in mouse EFs by IFNs in a ISGF3-
dependent manner, and the de¢ciency of the p48 null EFs in
the IFN-K gene induction can be rescued by an ectopic ex-
pression of IRF-7. In fact, the spectrum of the IFN-K gene
family induced in IRF-7-expressing p48 null EFs is essentially
the same as that of the wild-type EFs, further supporting the
notion that IRF-7 is the bona ¢de transcription factor gov-
erning the IFN-K gene induction.
It is interesting to note that the expression of IRF-7 also
a¡ects the IFN-L gene. In this context, one may recall that in
macrophages from p48 null mice, IFN-L m RNA induction by
NDV is also decreased by 10 fold compared to wild-type
macrophages [17]. We infer that in these cells the IRF-7 path-
way is important for maximal IFN-L gene induction, possibly
owing to the limitation of IRF-3 and/or its function in these
cells. It is also possible that the IRF-7 gene can be induced
not only by IFNs but also by other stimuli in an ISGF3-
independent manner, so as to insure prompt induction of
the IFN-K and -L genes in vivo. In this regard, it is interesting
that a high level expression of IFN-K mRNAs was detected in
the splenocytes isolated from NDV-infected, p48 null mice
(M.S., unpublished data).
The more detailed mechanism by which IRF-7 activates the
IFN-K (and IFN-L) gene transcription remains to be clari¢ed.
It has been shown that IRF-3 interacts, when activated by
virus, with the co-activator CBP/p300. In this regard, our
EMSA data indicates that the NDV induction-speci¢c band
involving IRF-7 migrates as slowly as the previously identi¢ed
IRF-3:CBP/p300 complex (data not shown), raising the pos-
sibility that IRF-7 also interacts with these co-activators. Un-
like IRF-3 which apparently acts on IFN-L gene, but not IFN-
K genes, IRF-7 seems to be active on both genes. One may
envisage that IRF-3 functions only in combination with other
factors, such as NF-UB, which is critical for the former but
not the latter gene induction [28], whereas IRF-7 is more
independent on other factors to activate these genes. The pos-
sibility also remains that IRF-7 can function only in the pres-
ence of IRF-3, by forming a complex [10]. These are interest-
ing future issues to be addressed, and work is in progress to
generate mice de¢cient in the IRF-3 and/or IRF-7 alleles.
Our present ¢ndings may have some implications regarding
to how the type I IFN gene subtypes, i.e. IFN-K genes and
IFN-L gene, have evolved, as well as to the biological signi¢-
cance of the regulation of this gene family. The results pre-
sented here reemphasize the presence of the positive feedback
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Fig. 4. The positive feedback regulation of the IFN-K/L production
mediated by IRF-3 and IRF-7. In this two-step activation model,
IRF-3, which is expressed in uninfected cells, is ¢rst activated by vi-
rus, translocates into nucleus to act on the IFN-L, but not IFN-K
genes, resulting in the initial production of IFN-L. IFN-L signals
through its receptor to induce IRF-7 gene expression via activation
of ISGF3, and IRF-7 then acts on IFN-K and IFN-L genes, pro-
vided that it undergoes virus-induced activation by phosphorylation.
The sequential operation of the two steps was revealed in the
present study for the mouse EFs, however, it is possible that they
may operate simultaneously in cells where IRF-7 may be induced
by other yet unknown stimuli. Numbers in circles indicate the se-
quence of the events.
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regulation mechanism of IFN production during virus infec-
tion, i.e. a more elaborated, two-step induction model, as
illustrated in Fig. 4. In this model, constitutively expressed
IRF-3 is ¢rst activated by virus-induced phosphorylation, re-
sulting in IFN-L gene induction. This initially produced IFN-L
then signals target cells to activate ISGF3, which in turn in-
duces the IRF-7 gene. IRF-7 then acts on both IFN-K and
IFN-L genes, provided once again that it has undergone virus-
induced activation by phosphorylation. The operation of this
regulatory mechanism is almost certainly critical for the im-
mediate response (i.e. innate immune response [1,2,29]) of the
host, potently limiting virus replication. One may also spec-
ulate that the IFN-L gene might represent the prototype IFN
gene whose expression has come under the control of IRF-3,
and that IFN-K genes, derived by gene duplication, have
evolved to promote a rapid, e⁄cient ampli¢cation mechanism
for IFN production under the control of IRF-7.
After completion of this work, we learnt that D. Levy and
colleagues obtained results similar to ours (Isabelle et al.,
EMBO J., in press), and that P. Pitha and colleagues obtained
data for the potential role of IRF-7 in the IFN-K gene expres-
sion [30].
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